TherapeuticsMD (TXMD) Retained Earnings (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Retained Earnings came in at -$952.3 million in Q1 2026, little changed YoY from -$952.1 million in Q1 2025, and little changed on a QoQ basis from -$952.4 million in Q4 2025.
TherapeuticsMD (TXMD) Retained Earnings (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Retained Earnings data on file, last reported at -$952.3 million in Q1 2026.
- Quarterly Retained Earnings changed 0.02% year-over-year to -$952.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$952.3 million (changed 0.02% YoY) and the FY2025 annual result came in at -$952.4 million, changed 0.06% from the prior year.
- Retained Earnings was little changed at -$952.3 million in Q1 2026, from -$952.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $979.2 million in Q3 2024 to a low of -$1.1 billion in Q1 2022.
- A 5-year average of -$737.5 million and a median of -$951.8 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 203.82% — and 2025, when it sank 197.29%.
- Tracing TXMD's Retained Earnings over 5 years: stood at -$939.4 million in 2022, then retreated by 1.09% to -$949.6 million in 2023, then decreased by 0.23% to -$951.8 million in 2024, then decreased by 0.06% to -$952.4 million in 2025, then grew by 0.01% to -$952.3 million in 2026.
- The last three Retained Earnings figures came in at -$952.3 million (Q1 2026), -$952.4 million (Q4 2025), and -$951.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.61 Bn | 39.96 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.39 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 3.75 Bn |
| 10 | TherapeuticsMD | 23.73 Mn | 14.54 Mn | - | -952.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -952.14 Mn |
| Mar 31, 2026 | -952.30 Mn |
| Dec 31, 2025 | -952.39 Mn |
| Sep 30, 2025 | -951.77 Mn |
| Jun 30, 2025 | -951.92 Mn |
| Mar 31, 2025 | -952.48 Mn |
| Dec 31, 2024 | -951.82 Mn |
| Sep 30, 2024 | 979.16 Mn |
| Jun 30, 2024 | -951.47 Mn |
| Mar 31, 2024 | 979.03 Mn |
| Dec 31, 2023 | -949.64 Mn |
| Sep 30, 2023 | -948.76 Mn |
| Jun 30, 2023 | -945.38 Mn |
| Mar 31, 2023 | -942.97 Mn |
| Dec 31, 2022 | -939.36 Mn |
| Sep 30, 2022 | -1.02 Bn |
| Jun 30, 2022 | -988.10 Mn |
| Mar 31, 2022 | -1.10 Bn |
| Dec 31, 2021 | -1.05 Bn |
| Sep 30, 2021 | -1.01 Bn |